Luke Harris
Impact in
-
- Cannabis and Cannabinoid Research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Cancer therapeutics and mechanisms 3
-
- Synthesis and pharmacology of benzodiazepine derivatives 4
- Co-authors
- Albert E. Munson (2 shared papers)Richard A. Carchman (1 shared paper)Philip M. Carabateas (2 shared papers)Sara Smith (1 shared paper)Michael L. Miller (5 shared papers)Ravi Chari (5 shared papers)Rajeeva Singh (3 shared papers)S. G. Bradley (1 shared paper)
- Journals
- ACS Medicinal Chemistry Letters (2 papers)Molecular Pharmaceutics (2 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Luke Harris
14 papers receiving 207 citations
Peers
Comparison fields: 5 of 58
- Pharmacology 88
- Radiology, Nuclear Medicine and Imaging 59
- Oncology 68
- Immunology 36
- Cellular and Molecular Neuroscience 31
Countries citing papers authored by Luke Harris
This map shows the geographic impact of Luke Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Harris more than expected).
Fields of papers citing papers by Luke Harris
This network shows the impact of papers produced by Luke Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Harris. The network helps show where Luke Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The inhibition of DNA synthesis by cannabinoids. | 1976 | 52 |
| 2 | 1978 | 34 | |
| 3 | 2019 | 33 | |
| 4 | 1966 | 27 | |
| 5 | 1979 | 14 | |
| 6 | 2018 | 13 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 10 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 9 | |
| 11 | 1964 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2018 | 2 | |
| 14 | 2016 | 1 | |
| 15 | 1993 | 0 |
About Luke Harris
Luke Harris is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 15 papers that have together received 226 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer therapeutics and mechanisms (3 papers), Cannabis and Cannabinoid Research (2 papers), Diet, Metabolism, and Disease (1 paper), Cell Image Analysis Techniques (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Pharmacology (88 citations), Radiology, Nuclear Medicine and Imaging (59 citations), Oncology (68 citations), Immunology (36 citations) and Cellular and Molecular Neuroscience (31 citations). Luke Harris has collaborated with scholars based in United States. Frequent co-authors include Albert E. Munson, Richard A. Carchman, Philip M. Carabateas, Sara Smith, Michael L. Miller, Ravi Chari, Rajeeva Singh, S. G. Bradley, Katie E. Archer and Thomas A. Keating. Their work appears in journals such as ACS Medicinal Chemistry Letters, Molecular Pharmaceutics, Journal of Medicinal Chemistry, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.